BPH	Benign prostatic hyperplasia
CCR	Clinical cure rate
CNKI	China National Knowledge Infrastructure
EC	Epicatechin
ECG	Epicatechin-3-gallate
EGC	Epigallocatechin
EGCG	Epigallocatechin-3-gallate
EOT	End-of-treatment
EPS	Extracellular polymeric substance
HQ	Hydroquinone
IL	Interleukin
LUTD	Lower urinary tract dysfunction
LUTS	Lower urinary tract symptoms
MIC	Minimum inhibitory concentration
NRF2	NF-E2-related factor 2
PACs	Proanthocyanidins
PAE	Post-antibiotic effect
PRP	Platelet-rich plasma
QS	Quorum sensing
RR	Risk ratio
rUTIs	Recurrent urinary tract infections
THMs	Traditional herbal medicines
TSA	Trial sequential analysis
UPEC	Uropathogenic Escherichia coli
UTI	Urinary tract infection